Download Files:
Products Details
Product Description
– LEM-14-1189, a LEM-14 (HY-114340) derivative, is a NSDs inhibitor with IC50s of 418 μM (NSD1), 111 μM (NSD2), and 60 μM (NSD3), respectively. The NSDs, histone lysine methyltransferases (HMTases), are oncoproteins, drivers of a number of tumors. LEM-14-1189 can be used for multiple myeloma (MM) research[1].
Web ID
– HY-125244
Shipping
– Room temperature
Molecular Formula
– C35H34N6O5S2
References
– [1]Shen Y, et al. Identification of LEM-14 inhibitor of the oncoprotein NSD2. Biochem Biophys Res Commun. 2019 Jan 1;508(1):102-108.
Molecular Weight
– 682.81
SMILES
– O=C(C(OC1=O)=CC2=C1C=CC=C2)NCCCN(CC3=NC4=C(C5=C(CCCC5)S4)C(N3)=O)CC6=NC7=C(C8=C(CCCC8)S7)C(N6)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Histone Methyltransferase
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
